2020 Digest (Vol 30 No 1)

Recently, OMIC made significant payments to settle two claims alleging delay in diagnosis and treatment of acanthamoeba keratitis (AK). Defense experts in these cases noted that AK is rare, difficult to diagnose and treat, and usually leads to poor outcomes. These settlements prompted our Claims Committee to ask Risk Management to review similar lawsuits. More…

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Expertise unmatched.

OMIC's sole mission is to serve ophthalmology. The premier source of ophthalmic claims data and loss prevention materials, OMIC's member hotline is the most used ophthalmic consultative service of its kind and OMIC.com is the most visited web site in America for ophthalmic risk management advice and patient consent documents.